ネトリン 1 ブロックは,子宮内膜がんにおける腫瘍成長とEMT特性を阻害する
Philippe A Cassier1, Raul Navaridas2, Melanie Bellina3,4
1Centre Léon Bérard, Departement de Recherche Clinique, Centre de recherche en cancérologie de Lyon INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, France.
Nature
|August 2, 2023
まとめ
抗体NP137によるNetrin- 1阻害は子宮内膜がん (EC) の治療において有望である. 腫瘍の進行を減少させ,上皮からメゼンキマへの移行を阻害し,化学療法への反応を改善した.
科学分野:
- 腫瘍学
- 癌 生物学
- 免疫療法
背景:
- 腫瘍の成長を促進する.
- 子宮内膜がん (EC) は,高いネットリン-1発現を示しています.
- Epithelial- to- mesenchymal transition (EMT) は,治療に対する耐性を高めるのに寄与している.
研究 の 目的:
- 子宮内膜がんにおける抗ネトリン-1抗体 (NP137) を用いてネトリン-1阻害の有効性を評価する.
- EMTと腫瘍の微小環境への影響を含むNP137の作用メカニズムを調査する.
- 標準化学療法とNP137の組み合わせ治療をECマウスモデルで評価する.
主な方法:
- ECマウスモデルでNP137を用いたNetrin-1阻害
- 先進的なEC患者でのNP137の臨床試験
- 腫瘍遺伝子プロファイリング,大量RNA-seq,空間トランスクリプトミクス,および患者バイオプシーの単細胞RNA-seq.
- ECマウスモデルにおけるNP137とカルボプラチンパクリタキセルの併用療法
主要な成果:
- NP137は,マウスモデルとヒトEC患者 (8/ 14 安定した疾患,1 回の部分応答) の両方で腫瘍進行を抑制する効果を示した.
- NP137は腫瘍上皮からメゼンキマへの移行 (EMT) を阻害し,細胞死を引き起こし,免疫浸透を変化させた.
- ECマウスモデルでは,NP137とカルボプラチンパクリタキセルを併用した治療は,単独の化学療法よりも優れた結果を示した.
結論:
- NP137によるNetrin-1阻害は,子宮内膜がんに対する有望な臨床戦略である.
- NP137は,EMTの解体および抑制を誘導し,治療抵抗性を克服することによって,抗腫瘍効果を発揮する.
- このアプローチは,高度なECにおける標準的な化学療法の有効性を高める可能性があります.
関連する概念動画
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:19Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K